Regulation of glucocorticoid receptor steroid binding and trafficking by the hsp90/hsp70-based chaperone machinery: Implications for clinical intervention

Leukemia

Volumn 19, Issue 5, 2005, Pages 710-712

  Murphy, P J M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 N ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; ANTINEOPLASTIC AGENT; BAG 1 PROTEIN; BCR ABL PROTEIN; BUTYRIC ACID; CHAPERONE; DOXORUBICIN; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELDANAMYCIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE INHIBITOR; IMATINIB; IMMUNOPHILIN; PACLITAXEL; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN INHIBITOR; PROTEIN P23; PROTEIN P50; STEROID RECEPTOR; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG; VORINOSTAT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CORRELATION ANALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MONOTHERAPY; PEDIATRICS; PREDICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SOLID TUMOR; STEROID BINDING; TREATMENT FAILURE; TREATMENT OUTCOME; UPREGULATION;

EID: 18644385292     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403687     Document Type: Article

References (24)

1. Tissing WJE, Meijerink JPP, den Boer ML, Brinkhof B, Pieters R. mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL. Leukemia 2005; 10 March [E-pub ahead of print].
2. Lauten M, Beger C, Gerdes K, Asgedom G, Kardinal C, Welte K et al. Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia. Leukemia 2003; 17: 1551-1556.
3. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209-1217.
4. Tissing WJE, Meijerink JPP, den Boer ML, Pieters R. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003; 17: 17-25.
5. Haarman EG, Kaspers GJ, Veerman AJ. Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation. Br J Haematol 2003; 120: 919-929.
6. Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 1993; 27: 437-496.
7. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997; 18: 306-360.
8. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 2003; 228: 111-133.
9. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993; 14: 459-479.
10. Sanchez ER, Meshinchi S, Tienrungroj W, Schlesinger MJ, Toft DO, Pratt WB. Relationship of the 90-kDa murine heat shock protein to the untransformed and transformed states of the L cell glucocorticoid receptor. J Biol Chem 1987; 262: 6986-6991.
11. Murphy PJM, Kanelakis KC, Galigniana MD, Morishima Y, Pratt WB. Stoichiometry, abundance, and functional significance of the hsp90/hsp70-based multiprotein chaperone machinery in reticulocyte lysate. J Biol Chem 2001; 276: 30092-30098.
12. Murphy PJM, Morishima Y, Chen H, Galigniana MD, Mansfield JF, Simons Jr SS et al. Visualization and mechanism of assembly of a glucocorticoid receptor · hsp70 complex that is primed for subsequent hsp90-dependent opening of the steroid binding cleft. J Biol Chem 2003; 278: 34764-34773,
13. Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor · hsp90 heterocomplexes formed by hsp90 · p60 · hsp70. J Biol Chem 1997; 272: 21213-21220.
14. Harrell JM, Murphy PJM, Morishima Y, Chen H, Mansfield JF, Galigniana MD et al. Evidence for glucocorticoid receptor transport on microtubules by dynein. J Biol Chem 2004; 279: 54647-54654.
15. Kanelakis KC, Morishima Y, Dittmar KD, Galigniana MD, Takayama S, Reed JC et al. Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery. J Biol Chem 1999; 274: 34134-34140.
16. Kanelakis KC, Murphy PJM, Galigniana MD, Morishima Y, Takayama S, Reed JC et al. Hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1. Biochemistry 2000; 39: 14314-14321.
17. Yufu Y, Nishimura J, Nawata H. High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leukemia Res 1992; 16: 597-605.
18. Kojika S, Sugita K, Inukai T, Saito M, Iijima K, Tezuka T et al. Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70kDa heat shock proteins. Leukemia 1996; 10: 994-999.
19. Grenert JP, Sullivan WP, Fadden P, Haystead TA, Clark J, Mimnaugh E et al. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem 1997; 272: 23843-23850.
20. Supko JG, Hickman RL, Grever MR, Malspeis L. Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol 1995; 36: 305-315.
21. Pratt WB. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol Med 1998; 217: 420-434.
22. Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 2002; 8: S55-S61.
23. Rahmani M, Yu C, Dai Y, Reese E, Ahmed W, Dent P et al. Coadministration of the heat shock protein 90 antagonist 17-allylamino-17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. Cancer Res 2003; 63: 8420-8427.
24. Blagosklonny MV, Fojo T, Bhalla KN, Kim JS, Trepel JB, Figg WD et al. The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy. Leukemia 2001; 15: 1537-1543.